| Thiazole–aminopiperidine hybrid analogues: Design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors VU Jeankumar, J Renuka, P Santosh, V Soni, JP Sridevi, P Suryadevara, ... European journal of medicinal chemistry 70, 143-153, 2013 | 84 | 2013 |
| Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline Z Wang, V Soni, G Marriner, T Kaneko, HIM Boshoff, CE Barry III, KY Rhee Proceedings of the National Academy of Sciences 116 (39), 19646-19651, 2019 | 43 | 2019 |
| Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening S Saxena, PB Devi, V Soni, P Yogeeswari, D Sriram Journal of Molecular Graphics and Modelling 47, 37-43, 2014 | 42 | 2014 |
| Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen V Soni, S Upadhayay, P Suryadevara, G Samla, A Singh, P Yogeeswari, ... PLoS pathogens 11 (10), e1005235, 2015 | 41 | 2015 |
| Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl … PKA Jagtap, V Soni, N Vithani, GD Jhingan, VS Bais, VK Nandicoori, ... Journal of Biological Chemistry 287 (47), 39524-39537, 2012 | 32 | 2012 |
| Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads VU Jeankumar, J Renuka, VK Pulla, V Soni, JP Sridevi, P Suryadevara, ... International journal of antimicrobial agents 43 (3), 269-278, 2014 | 31 | 2014 |
| Immunotherapy: an alternative promising therapeutic approach against cancers SL Gupta, S Basu, V Soni, RK Jaiswal Molecular Biology Reports 49 (10), 9903-9913, 2022 | 30 | 2022 |
| Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus R Janupally, VU Jeankumar, KA Bobesh, V Soni, PB Devi, VK Pulla, ... Bioorganic & Medicinal Chemistry 22 (21), 5970-5987, 2014 | 28 | 2014 |
| Oral Delivery of Cholic Acid-Derived Amphiphile Helps in Combating Salmonella-Mediated Gut Infection and Inflammation K Yadav, PS Yavvari, S Pal, S Kumar, D Mishra, S Gupta, M Mitra, V Soni, ... Bioconjugate Chemistry 30 (3), 721-732, 2019 | 27 | 2019 |
| Chemical–genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy EI Koh, PO Oluoch, N Ruecker, MK Proulx, V Soni, KC Murphy, ... Proceedings of the National Academy of Sciences 119 (15), e2201632119, 2022 | 23 | 2022 |
| Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase GO Petersen, S Saxena, J Renuka, V Soni, P Yogeeswari, DS Santos, ... Journal of Molecular Graphics and Modelling 60, 124-131, 2015 | 21 | 2015 |
| Targeting NAMPT for therapeutic intervention in cancer and inflammation: structure‐based drug design and biological screening VK Pulla, DS Sriram, V Soni, S Viswanadha, D Sriram, P Yogeeswari Chemical Biology & Drug Design 86 (4), 881-894, 2015 | 17 | 2015 |
| Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking … V Soni, P Suryadevara, D Sriram, OSDD Consortium, S Kumar, ... Journal of molecular modeling 21, 1-12, 2015 | 16 | 2015 |
| Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: a study against active, dormant and resistant tuberculosis JP Sridevi, P Suryadevara, R Janupally, J Sridhar, V Soni, HS Anantaraju, ... European Journal of Pharmaceutical Sciences 72, 81-92, 2015 | 16 | 2015 |
| Potential of Extremophiles for Bioremediation S Kaushik, A Alatawi, SR Djiwanti, A Pande, E Skotti, V Soni Microbial Rejuvenation of Polluted Environment, 293-328, 2021 | 15 | 2021 |
| Discovery of novel lysine ɛ-aminotransferase inhibitors: an intriguing potential target for latent tuberculosis PB Devi, JP Sridevi, SS Kakan, S Saxena, VU Jeankumar, V Soni, ... Tuberculosis 95 (6), 786-794, 2015 | 15 | 2015 |
| B-cell-based immunotherapy: A promising new alternative SL Gupta, N Khan, S Basu, V Soni Vaccines 10 (6), 879, 2022 | 13 | 2022 |
| Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis S Ma, R Morrison, SJ Hobbs, V Soni, J Farrow-Johnson, A Frando, ... Nature microbiology 6 (1), 44-50, 2021 | 12 | 2021 |
| The bifunctional protein GlmU is a key factor in biofilm formation induced by alkylating stress in Mycobacterium smegmatis A Di Somma, M Caterino, V Soni, M Agarwal, P di Pasquale, S Zanetti, ... Research in microbiology 170 (4-5), 171-181, 2019 | 12 | 2019 |
| Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility Y Patel, V Soni, KY Rhee, JD Helmann Mbio 14 (2), e03168-22, 2023 | 11 | 2023 |
D SriramSenior Professor, Department of Pharmacy, BITS-Pilani, Hyderabad CampusVerified email at hyderabad.bits-pilani.ac.in
